BIOSEARLAB CIC

Company limited by guarantee

Company Registration Number:
11738016 (England and Wales)

Unaudited statutory accounts for the year ended 31 December 2024

Period of accounts

Start date: 1 January 2024

End date: 31 December 2024

BIOSEARLAB CIC

Contents of the Financial Statements

for the Period Ended 31 December 2024

Directors report
Profit and loss
Balance sheet
Additional notes
Community Interest Report

BIOSEARLAB CIC

Directors' report period ended 31 December 2024

The directors present their report with the financial statements of the company for the period ended 31 December 2024

Principal activities of the company

BiosearLab CIC engages in collaborative research between academia and external organisations. The business model is that BiosearLab provides funding for pilot research work with the view of applying together with the academic partners for larger grants. In 2024 BiosearLab has financially supported a lab based project designed to demonstrate the 'sociability enhancing' properties of a non-alcoholic drink. The work has progressed satisfactorily but it has not reached the stage where additional grants can be applied for. The income of BiosearLab has come from personal investments of the director Stefano Casalotti to cover the expenses of the research work. In 2024 BiosearLab has also started to sponsor a PhD studentship for a refugee student at UEL. The funding has come from the director personal finance. The director has also provided its services with no remuneration to a public health research project to investigate the work of charity that provides services to people with alcohol and drug use problems.



Directors

The director shown below has held office during the whole of the period from
1 January 2024 to 31 December 2024

Stefano Casalotti


The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
2 August 2025

And signed on behalf of the board by:
Name: Stefano Casalotti
Status: Director

BIOSEARLAB CIC

Profit And Loss Account

for the Period Ended 31 December 2024

2024 2023


£

£
Turnover: 7,024 10,452
Cost of sales: ( 41,732 ) ( 10,294 )
Gross profit(or loss): (34,708) 158
Operating profit(or loss): (34,708) 158
Profit(or loss) before tax: (34,708) 158
Profit(or loss) for the financial year: (34,708) 158

BIOSEARLAB CIC

Balance sheet

As at 31 December 2024

Notes 2024 2023


£

£
Current assets
Cash at bank and in hand: 1,490 1,956
Total current assets: 1,490 1,956
Net current assets (liabilities): 1,490 1,956
Total assets less current liabilities: 1,490 1,956
Total net assets (liabilities): 1,490 1,956
Members' funds
Profit and loss account: 1,490 1,956
Total members' funds: 1,490 1,956

The notes form part of these financial statements

BIOSEARLAB CIC

Balance sheet statements

For the year ending 31 December 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 4 August 2025
and signed on behalf of the board by:

Name: Stefano Casalotti
Status: Director

The notes form part of these financial statements

BIOSEARLAB CIC

Notes to the Financial Statements

for the Period Ended 31 December 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

BIOSEARLAB CIC

Notes to the Financial Statements

for the Period Ended 31 December 2024

  • 2. Employees

    2024 2023
    Average number of employees during the period 0 0

COMMUNITY INTEREST ANNUAL REPORT

BIOSEARLAB CIC

Company Number: 11738016 (England and Wales)

Year Ending: 31 December 2024

Company activities and impact

BiosearLab CIC was set up to develop collaboarative research projects between academics and external organisation while offering training opportunities to recently graduate students. This year we have continued our industry-collaborative research project on the mechanism of action of a non-alcoholic drink that has potential sociability enhancement effects. This work could contribute to the development of non-alcoholic drinks that satisfy the public and reduce the serious medical and economic disadvantage caused by excessive alcohol consumption. Three graduate students have been involved in the project, one of which has progressed in obtaining a graduate training position within the NHS. Additionally BiosearLab has contributed to a collaborative research project with a charity that supports people with alcohol and drug addictions. Progress is being made on scientifically analysing the specific supportive approach that the charity has. Two graduate students have been involved in this work.

Consultation with stakeholders

BiosearLab has been conducting joint research with the charity Build on Belief which provides support services for people with alcohol and drug use problems. We hold regular meeting with the CEO and research lead of the charity to ensure that the research we carry out benefits Build on Belief and their clients. We have received positive feedback from the CEO and their board of trustees is keen for the collaboration to continue.

Directors' remuneration

No remuneration was received

Transfer of assets

No transfer of assets other than for full consideration

This report was approved by the board of directors on
2 August 2025

And signed on behalf of the board by:
Name: Stefano Casalotti
Status: Director